HSDT Live signals | Maximize Profits with Getagraph.com

BUY 110331 min ago

@ $6.10

Issued: 8 Feb 2024 @ 14:18

Return: -21.09%

Live Chart Being Loaded With Signals

Commentary (24 Apr 2024 @ 16:00):

Stats
Today's Volume	17 210.00
Average Volume	411 770
Market Cap	4.27M
EPS	$0 ( 2024-03-28 )
Next earnings date	( $-2.70 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.330
ATR14	$0.111 (2.31%)

Insider Trading

Date	Person	Action	Amount	type
2023-12-01	Andreeff Dane	Buy	643	Common Stock
2023-11-30	Andreeff Dane	Buy	641	Common Stock
2023-12-14	Andreeff Dane	Buy	2 827	Common Stock
2023-12-14	Andreeff Dane	Buy	1 603	Common Stock
2023-12-14	Andreeff Dane	Buy	570	Common Stock

INSIDER POWER
100.00
Last 99 transactions
Buy: 12 106 108 \| Sell: 0

Helius Medical Correlation

10 Most Positive Correlations
PASG	0.818
BPRN	0.81

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Helius Medical Financials

Annual	2023
Revenue:	$644 000
Gross Profit:	$-101 000 (-15.68 %)
EPS:	$-14.56

Q4	2023
Revenue:	$134 000
Gross Profit:	$36 000.00 (26.87 %)
EPS:	$-1.470

Q3	2023
Revenue:	$143 000
Gross Profit:	$-44 000.00 (-30.77 %)
EPS:	$-5.49

Q2	2023
Revenue:	$256 000
Gross Profit:	$72 000.00 (28.13 %)
EPS:	$-2.92

Financial Reports:

No articles found.

Helius Medical

Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company is headquartered in Newtown, Pennsylvania.